| Literature DB >> 34946864 |
Chung-Cheng Kao1, Hsiang-En Hsu2, Yi-Chou Chen3,4, Ming-Yu Tu5, Su-Wen Chuang2,6, Sui-Lung Su2.
Abstract
BACKGROUND: Osteoarthritis is an important health issue for the elderly. Many studies indicate that genetics is an important risk factor for osteoarthritis, and a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) is one gene that is most frequently implicated. Many recent studies have examined the relationship between a polymorphism in the ADAMTS5 gene (rs226794) and the risk for developing osteoarthritis without definitive results.Entities:
Keywords: ADAMTS5; case-control study; gene polymorphism; meta-analysis; osteoarthritis; trial sequential analysis
Mesh:
Substances:
Year: 2021 PMID: 34946864 PMCID: PMC8701278 DOI: 10.3390/genes12121916
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Distribution of the basic demographic variables of the study subjects.
| Knee OA Group ( | Control Group ( | ||
|---|---|---|---|
| Gender (%) | <0.001 * | ||
| Male | 219 (36.1%) | 277 (49.1%) | |
| Female | 387 (63.9%) | 287 (50.9%) | |
| Age (mean±SD) | 73.45 ± 7.30 | 71.61 ± 6.79 | <0.001 * |
| BMI | 24.58 ± 3.63 | 24.10 ± 3.31 | 0.021 * |
| SBP (mmHg) | 133.39 ± 17.84 | 130.90 ± 16.96 | 0.016 * |
| DBP (mmHg) | 77.13 ± 10.90 | 77.22 ± 11.09 | 0.882 |
| KL Grade (%) | <0.001 * | ||
| 0 | 0 | 23 (4.1%) | |
| 1 | 0 | 541 (95.9%) | |
| 2 | 452 (74.6%) | 0 | |
| 3 | 83 (13.7%) | 0 | |
| 4 | 71 (11.7%) | 0 |
Knee OA group: KL ≥ 2; control group: KL < 2; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. * p- value < 0.05.
Association between genetic polymorphism of ADAMTS5 rs226794 and knee osteoarthritis.
| Knee OA Group ( | Control Group ( | Crude-OR | Adj-OR a | |||
|---|---|---|---|---|---|---|
| Genotype | 0.667 | 0.785 | ||||
| AA | 173 (28.5%) | 148 (26.2%) | 1.00 | 1.00 | ||
| AG | 298 (49.2%) | 284 (50.4%) | 0.90 (0.68–1.18) | 0.438 | 0.91 (0.68–1.20) | 0.496 |
| GG | 135(22.3%) | 132 (23.4%) | 0.87 (0.63–1.21) | 0.421 | 0.96 (0.68–1.35) | 0.805 |
| Allele Model | 0.406 | 0.890 | ||||
| A | 644 (53.1%) | 580 (51.4%) | 1.00 | 1.00 | ||
| G | 568 (46.9%) | 548 (48.6%) | 0.93 (0.79–1.10) | 0.406 | 1.02 (0.76–1.36) | 0.890 |
| Dominant Model | 0.377 | 0.551 | ||||
| AA | 173 (28.5%) | 148 (26.2%) | 1.00 | 1.00 | ||
| AG+ GG | 433 (71.5%) | 416 (73.8%) | 0.89 (0.69–1.15) | 0.377 | 0.92 (0.70–1.21) | 0.551 |
| Recessive Model | 0.646 | 0.890 | ||||
| AA+AG | 471 (77.7%) | 432 (76.6%) | 1.00 | 1.00 | ||
| GG | 135 (22.3%) | 132 (23.4%) | 0.94 (0.71–1.23) | 0.646 | 1.02 (0.76–1.36) | 0.890 |
Knee OA group KL ≥ 2; control group: KL< 2; a: corrected age, gender, BMI; MAF (Taiwan Biobank): 47%; MAF (1000 Genome): 47%.
Figure 1Flow diagram of the identification process for eligible studies.
Figure 2Forest plot and funnel plot showing the association between ADAMTS5 rs226794 and OA.
Figure 3Trial sequential analysis (TSA) in Asians. We performed a TSA using an allele model assumption but replaced the allele count with the sample size (divided by 2). Detailed settings: significance level = 0.05; power = 0.8; ratio of controls to cases = 1; hypothetical proportion of controls with G allele = 0.30; least extreme OR to be detected = 1.2; I2 (heterogeneity) = 0%.
Figure 4Trial sequential analysis (TSA) in Caucasians. We performed a TSA using an allele model assumption but replaced the allele count with the sample size (divided by 2). Detailed settings: significance level = 0.05; power = 0.8; ratio of controls to cases = 1; hypothetical proportion of controls with G allele = 0.19; least extreme OR to be detected = 1.2; I2 (heterogeneity) = 28%.